Skip to main content
SpringerLink
Log in

Pruritus

  • Chapter
Therapy of Skin Diseases

  • 1476 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AD:

Atopic dermatitis.

CB:

Cannabinoid receptor.

CGPR:

Calcitonin gene-related peptide.

CNS:

Central nervous system.

DRG:

Dorsal root ganglia.

fMRI:

functional magnetic resonance imaging.

NGF:

Nerve growth factor.

PAR-2:

Proteinase-activated receptor-2

PEA:

Palmitoylethanolamine.

SP:

Substance P

Trp:

Transient receptor potential.

References

  1. Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M (2006) The neurobiology of itch. Nat Rev Neurosci 7:535–547

    Article  PubMed  CAS  Google Scholar 

  2. Ständer S, Streit M, Darsow U, Niemeier V, Vogelgsang M, Stander H et al (2006) Diagnostic and therapeutic procedures in chronic pruritis. J Dtsch Dermatol Ges 4:350–370

    Article  PubMed  Google Scholar 

  3. Ständer S (2006) Rational symptomatic therapy for chronic pruritus. Hautarzt 57:403–410

    Article  PubMed  Google Scholar 

  4. Ständer S, Schmelz M (2006) Chronic itch and pain–similarities and differences. Eur J Pain 10:473–478

    Article  PubMed  Google Scholar 

  5. Ständer S, Weisshaar E, Mettang T, Streit M, Darsow U, Schneider G et al (2006) Clinical classification of chronic pruritus: interdisciplinary consensus proposal for a diagnostic algorithm. Hautarzt 57:390–394

    Article  PubMed  Google Scholar 

  6. Bromm B, Scharein E, Darsow U, Ring J (1995) Effects of menthol and cold on histamine-induced itch and skin reactions in man. Neurosci Lett 187:157–160

    Article  PubMed  CAS  Google Scholar 

  7. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824

    Article  PubMed  CAS  Google Scholar 

  8. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V et al (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anand-amide. Nature 400:452–457

    Article  PubMed  CAS  Google Scholar 

  9. Jessell TM, Iversen LL, Cuello AC (1978) Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res 152:183–188

    Article  PubMed  CAS  Google Scholar 

  10. Ständer S, Luger T, Metze D (2001) Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol 44:471–478

    Article  PubMed  Google Scholar 

  11. Ständer S, Schmelz M, Metze D, Luger T, Rukwied R (2005) Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci 38:177–188

    Article  PubMed  Google Scholar 

  12. Dvorak M, Watkinson A, McGlone F, Rukwied R (2003) Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin. Inflamm Res 52:238–245

    PubMed  CAS  Google Scholar 

  13. Rukwied R, Watkinson A, McGlone F, Dvorak M (2003) Cannabinoid agonists attenuate capsaicin-induced responses in human skin. Pain 102:283–288

    Article  PubMed  CAS  Google Scholar 

  14. Szepietowski JC, Reich A, Szepietowski T (2005) Emollients with endocannabinoids in the treatment of uremic pruritus: discussion of the therapeutic options. Ther Apher Dial 9:277–279

    Article  PubMed  Google Scholar 

  15. Ständer S, Reinhardt HW, Luger TA (2006) Topical cannabi-noid agonists. An effective new possibility for treating chronic pruritus. Hautarzt 57:801–807

    Article  PubMed  Google Scholar 

  16. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM et al (2002) A TRP channel that senses cold stimuli and menthol. Cell 108:705–715

    Article  PubMed  CAS  Google Scholar 

  17. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR et al (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112:819–829

    Article  PubMed  CAS  Google Scholar 

  18. Senba E, Katanosaka K, Yajima H, Mizumura K (2004) The immunosuppressant FK506 activates capsaicin- and brady-kinin-sensitive DRG neurons and cutaneous C-fibers. Neurosci Res 50:257–262

    Article  PubMed  CAS  Google Scholar 

  19. Ständer S, Ständer H, Seeliger S, Luger TA, Steinhoff M (2007). Topical pimecrolimus (SDZ ASM 981) and tacroli-mus (FK 506) transiently induces neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol 156:1020–1026

    Article  PubMed  Google Scholar 

  20. Ständer S, Schürmeyer-Horst F, Luger TA, Weisshaar E (2006) Treatment of pruritic diseases with topical calcineu-rin inhibitors. Ther Clin Risk Manag 2:213–218

    Article  PubMed  Google Scholar 

  21. Hill SJ (1990) Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 42:45–83

    PubMed  CAS  Google Scholar 

  22. Gelfand EW, Appajosyula S, Meeves S (2004) Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research. Curr Med Res Opin 20:73–81

    Article  PubMed  CAS  Google Scholar 

  23. Andoh T, Kuraishi Y (2002) Inhibitory effects of azelastine on substance P-induced itch-associated response in mice. Eur J Pharmacol 436:235–239

    Article  PubMed  CAS  Google Scholar 

  24. Amsellem C, Czarlewski W, Lagarde M, Pacheco Y (1998) Inhibitory effect of loratadine on leukotriene B4 production by neutrophils either alone or during interaction with human airway epithelial cells. Pulm Pharmacol Ther 11:245–252

    Article  PubMed  CAS  Google Scholar 

  25. Lippert U, Kruger-Krasagakes S, Moller A, Kiessling U, Czarnetzki BM (1995) Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-lor-atadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 4:272–276

    Article  PubMed  CAS  Google Scholar 

  26. Schroeder JT, Schleimer RP, Lichtenstein LM, Kreutner W (2001) Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy 31:1369–1377

    Article  PubMed  CAS  Google Scholar 

  27. Wu P, Mitchell S, Walsh GM (2005) A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions. Clin Exp Allergy 35:1073–1079

    Article  PubMed  CAS  Google Scholar 

  28. Giustizieri ML, Albanesi C, Fluhr J, Gisondi P, Norgauer J, Girolomoni G (2004) H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 114:1176–1182

    Article  PubMed  CAS  Google Scholar 

  29. Vancheri C, Mastruzzo C, Tomaselli V, Bellistri G, Pistorio MP, Greco LR et al (2005) The effect of fexofena-dine on expression of intercellular adhesion molecule 1 and induction of apoptosis on peripheral eosinophils. Allergy Asthma Proc 26:292–298

    PubMed  CAS  Google Scholar 

  30. Dimkovic N, Djukanovic L, Radmilovic A, Bojic P, Juloski T (1992) Uremic pruritus and skin mast cells. Nephron 61:5–9

    Article  PubMed  CAS  Google Scholar 

  31. Francos GC, Kauh YC, Gittlen SD, Schulman ES, Besarab A, Goyal S et al (1991) Elevated plasma histamine in chronic uremia. Effects of ketotifen on pruritus. Int J Dermatol 30:884–889

    Article  PubMed  CAS  Google Scholar 

  32. Gillard M, Chatelain P (2006) Changes in pH differently affect the binding properties of histamine H1 receptor antagonists. Eur J Pharmacol 530:205–214

    Article  PubMed  CAS  Google Scholar 

  33. Bell JK, McQueen DS, Rees JL (2004) Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol 142:374–380

    Article  PubMed  CAS  Google Scholar 

  34. Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC et al (2003) Itch: scratching more than the surface. QJM 96:7–26

    Article  PubMed  CAS  Google Scholar 

  35. Andoh T, Kuraishi Y (1998) Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice. Eur J Pharmacol 353:93–96

    Article  PubMed  CAS  Google Scholar 

  36. Miyoshi M, Sakurai T, Kodama S (1999) Clinical evaluation of urinary leukotriene E4 levels in children with atopic dermatitis. Arerugi 48:1148–1152

    PubMed  CAS  Google Scholar 

  37. Bernardini N, Roza C, Sauer SK, Gomeza J, Wess J, Reeh PW (2002) Muscarinic M2 receptors on peripheral nerve endings: a molecular target of antinociception. J Neurosci 22:RC229

    PubMed  Google Scholar 

  38. Di Lorenzo G, Pacor ML, Mansueto P, Esposito-Pellitteri M, Ditta V, Lo Bianco C et al (2006) Is there a role for antileu-kotrienes in urticaria? Clin Exp Dermatol 31:327–334

    Article  Google Scholar 

  39. Carucci JA, Washenik K, Weinstein A, Shupack J, Cohen DE (1998) The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 134:785–786

    Article  PubMed  CAS  Google Scholar 

  40. Woodmansee DP, Simon RA (1999) A pilot study examining the role of zileuton in atopic dermatitis. Ann Allergy Asthma Immunol 83:548–552

    Article  PubMed  CAS  Google Scholar 

  41. Zabawski EJ Jr, Kahn MA, Gregg LJ (1999) Treatment of atopic dermatitis with zafirlukast. Dermatol Online J 5:10

    PubMed  Google Scholar 

  42. Takaoka A, Arai I, Sugimoto M, Honma Y, Futaki N, Nakamura A et al (2006) Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp Dermatol 15:161–167

    Article  PubMed  CAS  Google Scholar 

  43. Gaspari AA, Lotze MT, Rosenberg SA, Stern JB, Katz SI (1987) Dermatologic changes associated with interleukin 2 administration. JAMA 258:1624–1629

    Article  PubMed  CAS  Google Scholar 

  44. Darsow U, Scharein E, Bromm B, Ring J (1997) Skin testing of the pruritogenic activity of histamine and cytokines (inter-leukin-2 and tumour necrosis factor-alpha) at the dermal-epidermal junction. Br J Dermatol 137:415–417

    Article  PubMed  CAS  Google Scholar 

  45. Martin HA, Murphy PR (1995) Interleukin-2 activates a subpopulation of cutaneous C-fibre polymodal nociceptors in the rat hairy skin. Arch Physiol Biochem 103:136–148

    Article  PubMed  CAS  Google Scholar 

  46. Martin HA (1996) Bradykinin potentiates the chemorespon-siveness of rat cutaneous C-fibre polymodal nociceptors to interleukin-2. Arch Physiol Biochem 104:229–238

    Article  PubMed  CAS  Google Scholar 

  47. Wahlgren CF, Scheynius A, Hagermark O (1990) Antipruritic effect of oral cyclosporin A in atopic dermatitis. Acta Derm Venereol 70:323–329

    PubMed  CAS  Google Scholar 

  48. Andrew D, Craig AD (2001) Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 4:72–77

    Article  PubMed  CAS  Google Scholar 

  49. Jinks SL, Carstens E (2000) Superficial dorsal horn neurons identified by intracutaneous histamine: chemonociceptive responses and modulation by morphine. J Neurophysiol 84:616–627

    PubMed  CAS  Google Scholar 

  50. Drzezga A, Darsow U, Treede RD, Siebner H, Frisch M, Munz F et al (2001) Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain 92:295–305

    Article  PubMed  CAS  Google Scholar 

  51. Manenti L, Vaglio A (2005) Gabapentin for uraemic pruritus. Nephrol Dial Transplant 20:1278–1279

    Article  PubMed  Google Scholar 

  52. Yesudian PD, Wilson NJ (2005) Efficacy of gabapentin in the management of pruritus of unknown origin. Arch Dermatol 141:1507–1509

    Article  PubMed  CAS  Google Scholar 

  53. Schürmeyer-Horst F, Fischbach R, Nabavi D, Metze D, Ständer S (2006) Brachioradial pruritus: a rare, loalized, neuropathic form of itching. Hautarzt 57:523–527

    Article  PubMed  Google Scholar 

  54. Ben-Menachem E (2004) Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45(suppl 6):13–18

    Article  PubMed  CAS  Google Scholar 

  55. Wedekind D, Bandelow B (2005) The alpha2delta subunit of the voltage-dependent calcium channel. A new pharmaceutical target for psychiatry and neurology. Nervenarzt 76:888–891

    Article  PubMed  CAS  Google Scholar 

  56. Metze D, Reimann S, Luger TA (1999) Effective treatment of pruritus with naltrexone, an orally active opiate antagonist. Ann N Y Acad Sci 885:430–432

    Article  PubMed  CAS  Google Scholar 

  57. Metze D, Reimann S, Beissert S, Luger T (1999) Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 41:533–539

    PubMed  CAS  Google Scholar 

  58. Bergasa N V, Alling DW, Talbot TL, Wells MC, Jones EA (1999) Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 41:431–434

    Article  PubMed  CAS  Google Scholar 

  59. Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH et al (2006) Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 12:1125–1128

    PubMed  CAS  Google Scholar 

  60. Monroe EW (1989) Efficacy and safety of nalmefene in patients with severe pruritis caused by chronic urticaria and atopic dermatitis. J Am Acad Dermatol 21:135–136

    Article  PubMed  CAS  Google Scholar 

  61. Brune A, Metze D, Luger TA, Stander S (2004) Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients. Hautarzt 55:1130–1136

    Article  PubMed  CAS  Google Scholar 

  62. Tefferi A, Fonseca R (2002) Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus. Blood 99:2627

    Article  PubMed  CAS  Google Scholar 

  63. Zylicz Z, Smits C, Krajnik M (1998) Paroxetine for pruritus in advanced cancer. J Pain Symptom Manage 16:121–124

    Article  PubMed  CAS  Google Scholar 

  64. Zylicz Z, Krajnik M, Sorge AA, Costantini M (2003) Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage 26:1105–1112

    Article  PubMed  CAS  Google Scholar 

  65. Muller C, Pongratz S, Pidlich J, Penner E, Kaider A, Schemper M et al (1998) Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 10:865–870

    Article  PubMed  CAS  Google Scholar 

  66. Schworer H, Hartmann H, Ramadori G (1995) Relief of chole-static pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondanse-tron. Pain 61:33–37

    Article  PubMed  CAS  Google Scholar 

  67. Weisshaar E, Dunker N, Domrose U, Neumann KH, Gollnick H (2003) Plasma serotonin and histamine levels in hemodialysis-related pruritus are not significantly influenced by 5-HT3 receptor blocker and antihistaminic therapy. Clin Nephrol 59:124–129

    PubMed  CAS  Google Scholar 

  68. Zhang X, Huang J, McNaughton PA (2005) NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 24:4211–4223

    Article  PubMed  CAS  Google Scholar 

  69. Johansson O, Liang Y, Emtestam L (2002) Increased nerve growth factor- and tyrosine kinase A-like immunoreactivi-ties in prurigo nodularis skin — an exploration of the cause of neurohyperplasia. Arch Dermatol Res 293:614–619

    Article  PubMed  CAS  Google Scholar 

  70. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M (2002) Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147:71–79

    Article  PubMed  CAS  Google Scholar 

  71. Steinhoff M, Vergnolle N, Young SH, Tognetto M, Amadesi S, Ennes HS et al (2000) Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6:151–158

    Article  PubMed  CAS  Google Scholar 

  72. Obreja O, Rukwied R, Steinhoff M, Schmelz M (2006) Neurogenic components of trypsin- and thrombin-induced inflammation in rat skin, in vivo. Exp Dermatol 15:58–65

    Article  PubMed  CAS  Google Scholar 

  73. Ui H, Andoh T, Lee JB, Nojima H, Kuraishi Y (2006) Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur J Pharmacol 530:172–178

    Article  PubMed  CAS  Google Scholar 

  74. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS et al (2003) Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 23:6176–6180

    PubMed  CAS  Google Scholar 

  75. Sheskin J (1975) Treatment of prurigo nodularis Hyde using thalidomide. Hautarzt 26:215–217

    PubMed  CAS  Google Scholar 

  76. van den Broek H (1980) Treatment of prurigo nodularis with thalidomide. Arch Dermatol 116:571–572

    Article  PubMed  Google Scholar 

  77. Winkelmann RK, Connolly SM, Doyle JA, Padilha-Goncalves A (1984) Thalidomide treatment of prurigo nod-ularis. Acta Derm Venereol 64:412–417

    PubMed  CAS  Google Scholar 

  78. Maurer T, Poncelet A, Berger T (2004) Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy. Arch Dermatol 140:845–849

    Article  PubMed  CAS  Google Scholar 

  79. Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, Lugon JR (1994) Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 67:270–273

    Article  PubMed  CAS  Google Scholar 

  80. Daly BM, Shuster S (2000) Antipruritic action of thalidomide. Acta Derm Venereol 80:24–25

    Article  PubMed  CAS  Google Scholar 

  81. McCormick PA, Scott F, Epstein O, Burroughs AK, Scheuer PJ, McIntyre N (1994) Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study. J Hepatol 21:496–499

    Article  PubMed  CAS  Google Scholar 

  82. Ständer S, Böckenholt B, Schürmeyer-Horst F, Heuft G, Luger TA, Schneider G (2009) Treatment of Chronic Pruritus with the Selective Serotonin Re-uptake Inhibitors Paroxetine and Fluvoxamine: Results of an open-labeled, two-arm Proof-of-concept Study. Acta DermatoVenereol; 89:45–51

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Clinical Neurodermatology, Ludwig-Boltzmann Institute for Cell Biology and Immunobiology of the Skin, University of Münster, Von-Esmarch-Straβe 58, Münster, 48149, Germany

    Sonja Ständer

  2. Department of Dermatology, Clinical Neurodermatology, Ludwig-Boltzmann Institute for Cell Biology and Immunobiology of the Skin, University of Münster, Von-Esmarch-Straβe 58, Münster, 48149, Germany

    Thomas A. Luger

Authors
  1. Sonja Ständer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas A. Luger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sonja Ständer .

Editor information

Editors and Affiliations

  1. Universitätsklinikum Köln Klinik und Poliklinik für Dermatologie und Venerologie, Kerpener Str. 62, Köln, 50924, Germany

    Thomas Krieg

  2. Dept. Dermatology, Columbia University Medical Center, 12th Floor, Herbert Irving Pavilion 161 Fort Washington Ave, New York, NY, 10032, USA

    David R. Bickers

  3. Dept. Dermatology & Cutaneous Sciences, Kyoto University Graduate School of Medicine, 54 Kawahara-cho Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan

    Yoshiki Miyachi

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ständer, S., Luger, T.A. (2010). Pruritus. In: Krieg, T., Bickers, D.R., Miyachi, Y. (eds) Therapy of Skin Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78814-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78814-0_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78813-3

  • Online ISBN: 978-3-540-78814-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation